Compare MNOV & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNOV | FSI |
|---|---|---|
| Founded | 2000 | 1991 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.9M | 67.8M |
| IPO Year | 2004 | 2000 |
| Metric | MNOV | FSI |
|---|---|---|
| Price | $1.40 | $5.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 55.9K | 14.6K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 0.09 |
| Revenue | $2,360,807.00 | ★ $15,494,325.00 |
| Revenue This Year | N/A | $4.11 |
| Revenue Next Year | N/A | $58.09 |
| P/E Ratio | ★ N/A | $59.67 |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.13 | $3.46 |
| 52 Week High | $1.96 | $11.48 |
| Indicator | MNOV | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 49.17 |
| Support Level | $1.21 | $5.21 |
| Resistance Level | $1.43 | $5.47 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 24.25 | 43.33 |
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.